Powered by: Motilal Oswal
2025-11-12 11:39:56 am | Source: Motilal Oswal Financial Services Ltd
Buy State Bank of India Ltd for the Target Rs. 1,075 by Motilal Oswal Financial Services Ltd
Buy State Bank of India Ltd for the Target Rs. 1,075 by Motilal Oswal Financial Services Ltd

Steady quarter; NII growth surprises positively

Margins expand 7bp QoQ to 2.97%

* State Bank of India (SBIN) reported 2QFY26 PAT of INR201.6b (10% YoY growth, 21% beat), supported by an exceptional gain of INR45.9b from the divestment of 13.18% of its shareholding in Yes Bank. Adj. PAT stood at INR167b (in-line; down 9% YoY/13% QoQ).

* NII grew 3.3% YoY/4.7% QoQ to INR429.8b (6% beat). NIM stood at 2.97% (7bp QoQ rise), with domestic NIMs improving 7bp QoQ to 3.09%.

* Loan book grew 13% YoY/4% QoQ, while deposits grew 9.3% YoY/2.2% QoQ. CASA ratio stood at 39.6%.

* Slippages moderated to INR49.98b (vs INR84b in 1QFY26). GNPA/NNPA ratio improved 10bp/5bp QoQ to 1.73%/0.42%. PCR increased to 75.8%.

* We raise our adj. earnings by 5.8%/3.1% for FY26/27E and estimate FY27E RoA/RoE at 1.1%/15.5%. Reiterate BUY with a TP of INR1,075 (1.4x FY27E ABV + INR242 for subs).

 

Advances growth healthy; asset quality improves further

* SBIN reported 2QFY26 PAT of INR201.6b (10% YoY growth, 21% beat), supported by stake sale gains in Yes Bank and robust NII growth. Adj. PAT stood at INR167.7b (in-line; down 9% YoY/13% QoQ).

* NII grew 3.3% YoY/4.7% QoQ to INR429.8b (6% beat). NIM stood at 2.97% (7bp QoQ gain). SBIN expects FY26 domestic NIMs to be maintained at >3%.

* Other income stood flat YoY/declined 11.6% QoQ to INR153b (in-line) as treasury gains (excluding stake sale) stood at INR28.8b vs INR63.3b in 1QFY26. Core fee income, however, grew at a robust 25.4% YoY.

* Opex grew 12.3% YoY/11.2% QoQ to INR309.9b (6% higher than MOFSLe), led by GST, software, and training expenses. PPoP declined 7% YoY/declined 11% QoQ to INR273b (in-line).

* Advances grew healthy at 13% YoY/4% QoQ. Of this, retail grew 14% YoY/3.5% QoQ, agri grew 5.7% QoQ, and SME grew 19% YoY/2.7% QoQ. Corporate growth was 7% YoY/3% QoQ. Xpress credit grew 1.6% QoQ; the bank expects the segment to improve going forward.

* Provisions increased 20% YoY (20% higher than our estimate) to INR54b. Deposits grew 9.3% YoY/2.2% QoQ. CASA ratio stood at 39.6%. CD ratio increased to 78% vs 76.7% in 1QFY26.

* Slippages moderated to INR49.98b (slippage ratio at 0.45%). GNPA/NNPA ratio improved 10bp/5bp QoQ to 1.73%/0.42%, while PCR ratio increased to 75.8%. Credit cost moderated to 0.39%, while SMA book stood at 9bp of loans (12bp in 1QFY26).

* Subsidiaries: SBICARD clocked a PAT of INR4.5b (rising 10% YoY/declining 20% QoQ). SBILIFE’s PAT declined 6.4% YoY (down 17% QoQ) to INR4.95b. PAT of the AMC business grew 7% YoY/declined 12% QoQ to INR7.4b.

 

Highlights from the management commentary

* SBIN reiterates its domestic NIM guidance of over 3%. RoA would be 1.04% excluding stake sale gains.

* The bank has guided for loan growth of ~12-14%, led by growth across its business segments.

* The extraordinary gain from the Yes Bank stake sale was about INR45b gross of tax and INR33.86b net of tax.

* GST on expenses stood at INR10.8b in 2QFY26 vs INR6.62b in 2QFY25.

* The bank incurred training expenses of ~INR5.5b, as many of the new recruits are individuals preparing for examinations. The bank conducted extensive training programs to prepare them for various assignments.

 

Valuation and view

SBIN reported a steady quarter, led by robust NII, resilient margins, and one-off gains from the Yes Bank stake sale. NIM expanded 7bp QoQ to 2.97%, and management expects a further recovery in 3Q and 4Q, supported by improved liquidity from CRR cuts. Opex was higher due to GST and training expenses, while robust revenue growth resulted in in-line PPoP. Credit growth was healthy at 13% YoY, while a robust credit pipeline is expected to support a healthy outlook in FY26. Management guided FY26E loan growth at 12-14%. Asset quality also saw an improvement, with slippages improving and credit cost remaining benign at 39bp. We raise our adj. earnings by 5.8%/3.1% for FY26/27E and estimate FY27E RoA/RoE at 1.1%/15.5%. Reiterate BUY with a TP of INR1,075 (1.4x FY27E ABV + INR242 for subs).

 

 

For More Research Reports : Click Here 

For More Motilal Oswal Securities Ltd Disclaimer
http://www.motilaloswal.com/MOSLdisclaimer/disclaimer.html
SEBI Registration number is INH000000412

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here